GSK232 is primarily utilized in the field of medical research, particularly in the study of cardiovascular diseases. It functions as a potent and selective inhibitor of a specific enzyme that plays a critical role in regulating blood pressure and vascular function. Researchers employ GSK232 to investigate the mechanisms underlying hypertension and other related conditions, aiming to develop novel therapeutic strategies. Additionally, it is used in preclinical studies to evaluate its efficacy and safety profile, providing valuable insights for potential drug development. Its application extends to cellular and molecular studies, where it helps in understanding the signaling pathways involved in cardiovascular health and disease.